by McKesson Ventures | Mar 23, 2022 | Portfolio News
Synthetic data generation startup Replica Analytics was recently acquired by real world evidence technology company Aetion. Replica was first founded by members of the CHEO Research Institute and the University of Ottawa Faculty of Medicine. This acquisition...
by McKesson Ventures | Jan 4, 2022 | Press Releases
Regulatory-grade real-world evidence technology provider Aetion recently announced its acquisition of Replica Analytics. Replica Analytics is well known for creating synthetic health data through artificial intelligence programs. Replica will be able to help Aetion...
by McKesson Ventures | Dec 1, 2021 | Press Releases
Aetion has been selected by the European Medicines Agency to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion is a health care analytics company, working to provide real-world evidence for regulators, manufacturers, and purchasers of...
by McKesson Ventures | Oct 21, 2021 | Press Releases
Aetion announced that it is expanding its relationship with the U.S. Food and Drug Administration to use real-world evidence to study COVID-19 interventions and advance regulatory science and innovation. The FDA and Aetion will use the Aetion Evidence Platform,...
by McKesson Ventures | Sep 22, 2021 | Press Releases
Aetion and Quinten Health have partnered up to better provide a range of real-world evidence (RWE) generation products and services by reducing complexity, increasing efficiency, and supporting rapid turnaround times to improve patient outcomes. Aetion Co-Founder and...
